Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Increasing evidence have implied that microbiota from airway and gut might be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the cross-talk between respiratory and gastrointestinal microbiome in COPD is still undetermined. The study is aimed to investigate the interaction between lung and gut flora, and their role in the process of COPD.
Despite the high prevalence of chronic obstructive pulmonary disease (COPD), there continues to be a large gap in our understanding of disease pathogenesis and mechanisms accounting for large variability in disease phenotype. Cigarette smoking is the principal cause of COPD, but only approximately 15% of adults with substantial tobacco exposure develop clinical COPD. Besides, bacterial colonization or infection is also considered as an important factor in COPD. There are very limited data from microbiome studies that suggest that respiratory and gastrointestinal microbiota may be involved in the pathogenesis of COPD. However, the cross-talk between between lung and gut microbiome, and their relationship with various clinical phenotypes of COPD. Here, we conducted 16S rRNA-based pyrosequencing to evaluate the link between the lung-gut axis and the clinical phenotypes of COPD, such as lung function, emphysema, symptoms, exacerbations, inflammation levels and metabolic features.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COPD | Smokers with clinically stable chronic obstructive pulmonary disease (COPD) | ||
| healthy control | Age-matched subjects without chronic obstructive pulmonary disease (COPD) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Microbiota that can predict the progress of lung function | The study is aimed to investigate the relationship between the microbiota and the progress of lung function in COPD | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Bacteria related to inflammatory factors | The association between microbiota and inflammatory factors from host is also investigated | 6 months |
| Bacteria related to metabolomics | The association between microbiota and metabolites from host is also investigated |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Clinically stable patients with COPD and controls without COPD are enrolled.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Peking University Third Hospital | Beijing | Beijing Municipality | 100191 | China |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Oct 15, 2017 | |
| Reset | Jul 24, 2018 | |
| Release | Jul 25, 2018 | |
| Reset | Jan 15, 2019 | |
| Release | Aug 27, 2019 | |
| Reset | Sep 27, 2019 | |
| Release | Mar 16, 2024 | |
| Reset | Aug 14, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Oct 15, 2017 | Jul 24, 2018 | |||
| Jul 25, 2018 |
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Throat swab, induced sputum, bronchoalveolar lavage fluid (BALF) and faeces
| 6 months |
| Jan 15, 2019 |
| Aug 27, 2019 | Sep 27, 2019 |
| Mar 16, 2024 | Aug 14, 2024 |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |